3rd Quarter - Report

ALCON LABORATORIES, INC. for ALCON LABORATORIES INC

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Policies concerning annual ASC inflation index in OPPS/ASC Final Rules.

Foreign entity interest: Nestle S.A. is a foreign entity that as of September 30, 2009 owned 52.2 % of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Environment/Superfund ENV

Issues concerning implementation of the Montreal protocol.

Foreign entity interest: Nestle S.A. is a foreign entity that as of September 30, 2009 owned 52.2 % of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

"America's Healthy Future Act", S.1796 as it relates to the proposed excise tax on drugs and medical devices.

Foreign entity interest: Nestle S.A. is a foreign entity that as of September 30, 2009 owned 52.2 % of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.